Post-Graduation Program in Medicine: Medical Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Mol Genet Metab. 2011;104 Suppl:S80-5. doi: 10.1016/j.ymgme.2011.09.019. Epub 2011 Sep 20.
Recent studies showed that phenylalanine (Phe) plasma concentrations may decrease in some patients with hyperphenylalaninemia (HPA) due to phenylalanine hydroxylase (PAH) deficiency, after the administration of tetrahydrobiopterin (BH(4)).
To determine responsiveness to a single dose of BH(4) administered according to an innovative protocol using a combined Phe and BH(4) loading test in Brazilian phenylketonuria (PKU) patients.
Patient age should be ≥ 4 years, and median Phe plasma concentration ≤ 600 μmol/L when following dietary restrictions. Participants received a simple Phe loading test using 100mg/kg L-Phe (Test 1) and a combined Phe+BH(4) loading test using 100mg/kg L-Phe and 20mg/kg/BH(4) (Test 2). Blood samples were collected at baseline and 3, 11 and 27 h after Phe ingestion (T0, T1, T2 and T3). Responsiveness was defined as: criterion A: plasma Phe reduction of ≥ 30% at T1 and T2 for Tests 1 and 2; criterion B: plasma Phe reduction of ≥ 30% at T1 and T3 for Tests 1 and 2; and criterion C: at least 30% difference of the areas under the Phe curve for Tests 1 and 2.
Eighteen patients (median age 12 yrs; 8 classical PKU; 10 mild PKU) participated in the study. Six patients (2 classical PKU; 4 mild PKU) were classified as responsive according to at least one of the criteria. Responsiveness was concordant when criteria A + B we compared with criterion C (kappa = 0.557; p = 0.017). Of the patients whose genotype was available (n = 16), six had data about BH(4)-responsiveness genotypes described in the literature, which were in agreement with our findings.
The comparison of simple Phe loading and combined Phe + BH(4) loading seems to be an optimal method to evaluate responsiveness to BH(4) in patients with good metabolic control.
最近的研究表明,由于苯丙氨酸羟化酶(PAH)缺乏,一些高苯丙氨酸血症(HPA)患者在给予四氢生物蝶呤(BH4)后,其血浆苯丙氨酸(Phe)浓度可能会降低。
根据一项创新方案,使用苯丙氨酸和 BH4 联合负荷试验,确定在巴西苯丙酮尿症(PKU)患者中单剂量 BH4 给药的反应性。
患者年龄应≥4 岁,且在遵循饮食限制时,中值血浆 Phe 浓度应≤600μmol/L。参与者接受了简单的苯丙氨酸负荷试验(使用 100mg/kg L-Phe)和苯丙氨酸+BH4 联合负荷试验(使用 100mg/kg L-Phe 和 20mg/kg/BH4)(Test 2)。在苯丙氨酸摄入后 3、11 和 27 小时(T0、T1、T2 和 T3)采集基线和血样。反应性定义为:标准 A:Test 1 和 2 在 T1 和 T2 时,血浆 Phe 降低≥30%;标准 B:Test 1 和 2 在 T1 和 T3 时,血浆 Phe 降低≥30%;标准 C:Test 1 和 2 的苯丙氨酸曲线下面积至少相差 30%。
18 名患者(中位年龄 12 岁;8 名经典 PKU;10 名轻度 PKU)参与了研究。根据至少一个标准,有 6 名患者(2 名经典 PKU;4 名轻度 PKU)被归类为有反应。当比较标准 A+B 与标准 C 时,反应性是一致的(kappa=0.557;p=0.017)。在有可用基因型的患者中(n=16),有 6 名患者的数据与文献中描述的 BH4 反应性基因型相符,这与我们的发现一致。
简单的苯丙氨酸负荷和联合苯丙氨酸+BH4 负荷的比较似乎是评估代谢控制良好的患者对 BH4 反应性的最佳方法。